questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-tyrosine kinases
Protein-tyrosine kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protein-tyrosine kinases : Questions médicales les plus fréquentes",
"headline": "Protein-tyrosine kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protein-tyrosine kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-05",
"dateModified": "2025-04-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protein-tyrosine kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines et peptides de signalisation intracellulaire",
"url": "https://questionsmedicales.fr/mesh/D047908",
"about": {
"@type": "MedicalCondition",
"name": "Protéines et peptides de signalisation intracellulaire",
"code": {
"@type": "MedicalCode",
"code": "D047908",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agammaglobulinaemia tyrosine kinase",
"alternateName": "Agammaglobulinaemia Tyrosine Kinase",
"url": "https://questionsmedicales.fr/mesh/D000077329",
"about": {
"@type": "MedicalCondition",
"name": "Agammaglobulinaemia tyrosine kinase",
"code": {
"@type": "MedicalCode",
"code": "D000077329",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.025"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Focal adhesion protein-tyrosine kinases",
"alternateName": "Focal Adhesion Protein-Tyrosine Kinases",
"url": "https://questionsmedicales.fr/mesh/D051416",
"about": {
"@type": "MedicalCondition",
"name": "Focal adhesion protein-tyrosine kinases",
"code": {
"@type": "MedicalCode",
"code": "D051416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.049"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Janus kinases",
"alternateName": "Janus Kinases",
"url": "https://questionsmedicales.fr/mesh/D053612",
"about": {
"@type": "MedicalCondition",
"name": "Janus kinases",
"code": {
"@type": "MedicalCode",
"code": "D053612",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.124"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Janus kinase 1",
"alternateName": "Janus Kinase 1",
"url": "https://questionsmedicales.fr/mesh/D053613",
"about": {
"@type": "MedicalCondition",
"name": "Janus kinase 1",
"code": {
"@type": "MedicalCode",
"code": "D053613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.124.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Janus kinase 3",
"alternateName": "Janus Kinase 3",
"url": "https://questionsmedicales.fr/mesh/D053616",
"about": {
"@type": "MedicalCondition",
"name": "Janus kinase 3",
"code": {
"@type": "MedicalCode",
"code": "D053616",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.124.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "TYK2 Kinase",
"alternateName": "TYK2 Kinase",
"url": "https://questionsmedicales.fr/mesh/D053634",
"about": {
"@type": "MedicalCondition",
"name": "TYK2 Kinase",
"code": {
"@type": "MedicalCode",
"code": "D053634",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.124.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Mitogen-Activated Protein Kinase Kinases",
"alternateName": "Mitogen-Activated Protein Kinase Kinases",
"url": "https://questionsmedicales.fr/mesh/D020929",
"about": {
"@type": "MedicalCondition",
"name": "Mitogen-Activated Protein Kinase Kinases",
"code": {
"@type": "MedicalCode",
"code": "D020929",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 1",
"alternateName": "MAP Kinase Kinase 1",
"url": "https://questionsmedicales.fr/mesh/D048369",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 1",
"code": {
"@type": "MedicalCode",
"code": "D048369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 2",
"alternateName": "MAP Kinase Kinase 2",
"url": "https://questionsmedicales.fr/mesh/D048370",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 2",
"code": {
"@type": "MedicalCode",
"code": "D048370",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 3",
"alternateName": "MAP Kinase Kinase 3",
"url": "https://questionsmedicales.fr/mesh/D048371",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 3",
"code": {
"@type": "MedicalCode",
"code": "D048371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 4",
"alternateName": "MAP Kinase Kinase 4",
"url": "https://questionsmedicales.fr/mesh/D048670",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 4",
"code": {
"@type": "MedicalCode",
"code": "D048670",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 5",
"alternateName": "MAP Kinase Kinase 5",
"url": "https://questionsmedicales.fr/mesh/D048671",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 5",
"code": {
"@type": "MedicalCode",
"code": "D048671",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 6",
"alternateName": "MAP Kinase Kinase 6",
"url": "https://questionsmedicales.fr/mesh/D048669",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 6",
"code": {
"@type": "MedicalCode",
"code": "D048669",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "MAP Kinase Kinase 7",
"alternateName": "MAP Kinase Kinase 7",
"url": "https://questionsmedicales.fr/mesh/D048688",
"about": {
"@type": "MedicalCondition",
"name": "MAP Kinase Kinase 7",
"code": {
"@type": "MedicalCode",
"code": "D048688",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.200.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syk kinase",
"alternateName": "Syk Kinase",
"url": "https://questionsmedicales.fr/mesh/D000072377",
"about": {
"@type": "MedicalCondition",
"name": "Syk kinase",
"code": {
"@type": "MedicalCode",
"code": "D000072377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "src-Family kinases",
"alternateName": "src-Family Kinases",
"url": "https://questionsmedicales.fr/mesh/D019061",
"about": {
"@type": "MedicalCondition",
"name": "src-Family kinases",
"code": {
"@type": "MedicalCode",
"code": "D019061",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "CSK tyrosine-protein kinase",
"alternateName": "CSK Tyrosine-Protein Kinase",
"url": "https://questionsmedicales.fr/mesh/D000081247",
"about": {
"@type": "MedicalCondition",
"name": "CSK tyrosine-protein kinase",
"code": {
"@type": "MedicalCode",
"code": "D000081247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.800.158"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "ZAP-70 Protein-tyrosine kinase",
"alternateName": "ZAP-70 Protein-Tyrosine Kinase",
"url": "https://questionsmedicales.fr/mesh/D051746",
"about": {
"@type": "MedicalCondition",
"name": "ZAP-70 Protein-tyrosine kinase",
"code": {
"@type": "MedicalCode",
"code": "D051746",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.568.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protein-tyrosine kinases",
"alternateName": "Protein-Tyrosine Kinases",
"code": {
"@type": "MedicalCode",
"code": "D011505",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Angela L Tyner",
"url": "https://questionsmedicales.fr/author/Angela%20L%20Tyner",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA; University of Illinois Cancer Center, University of Illinois at Chicago, Chicago, Illinois, USA. Electronic address: atyner@uic.edu."
}
},
{
"@type": "Person",
"name": "Eiji Kinoshita",
"url": "https://questionsmedicales.fr/author/Eiji%20Kinoshita",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Molecular Science, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan."
}
},
{
"@type": "Person",
"name": "Emiko Kinoshita-Kikuta",
"url": "https://questionsmedicales.fr/author/Emiko%20Kinoshita-Kikuta",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Molecular Science, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan."
}
},
{
"@type": "Person",
"name": "Tohru Koike",
"url": "https://questionsmedicales.fr/author/Tohru%20Koike",
"affiliation": {
"@type": "Organization",
"name": "Department of Functional Molecular Science, Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima 734-8553, Japan."
}
},
{
"@type": "Person",
"name": "Gongqin Sun",
"url": "https://questionsmedicales.fr/author/Gongqin%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI, United States."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cloud Computing to Tourism Economic Data Scheduling Algorithm under the Background of Image and Video.",
"datePublished": "2022-07-21",
"url": "https://questionsmedicales.fr/article/35909867",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/3948221"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational simulations reveal that Abl activity controls cohesiveness of actin networks in growth cones.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35857718",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1091/mbc.E21-11-0535"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correction: Analysis of co-authorship networks among Brazilian graduate programs in computer science.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35849587",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0271937"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ultra-low-dose computed tomography for torsion measurements of the lower extremities in children and adolescents.",
"datePublished": "2022-07-15",
"url": "https://questionsmedicales.fr/article/35838922",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13244-022-01257-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computational and Experimental Evaluation of the Stability of a GLP-1-like Peptide in Ethanol-Water Mixtures.",
"datePublished": "2022-07-14",
"url": "https://questionsmedicales.fr/article/35890357",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/pharmaceutics14071462"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-tyrosine kinases",
"item": "https://questionsmedicales.fr/mesh/D011505"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protein-tyrosine kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protein-tyrosine kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protein-tyrosine kinases",
"description": "Comment diagnostiquer une dysrégulation des kinases à tyrosine ?\nQuels marqueurs sont utilisés pour le diagnostic ?\nLes tests génétiques sont-ils utiles ?\nQuels examens d'imagerie sont recommandés ?\nLes antécédents familiaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protein-tyrosine kinases",
"description": "Quels symptômes sont liés à une suractivité des kinases ?\nLes symptômes varient-ils selon le type de kinase ?\nY a-t-il des symptômes spécifiques aux cancers ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?\nComment les symptômes évoluent-ils dans le temps ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protein-tyrosine kinases",
"description": "Peut-on prévenir les dysfonctionnements des kinases ?\nLes dépistages réguliers sont-ils recommandés ?\nY a-t-il des vaccins préventifs ?\nLe tabagisme influence-t-il le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protein-tyrosine kinases",
"description": "Quels traitements ciblent les kinases à tyrosine ?\nLes traitements sont-ils personnalisés ?\nQuels effets secondaires des traitements sont courants ?\nLa radiothérapie est-elle utilisée ?\nLes traitements sont-ils efficaces à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protein-tyrosine kinases",
"description": "Quelles complications peuvent survenir avec les kinases ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles le pronostic ?\nLes complications varient-elles selon le type de cancer ?\nLes complications nécessitent-elles des traitements supplémentaires ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protein-tyrosine kinases",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de dysfonctionnement des kinases ?\nLe mode de vie joue-t-il un rôle ?\nLes infections peuvent-elles être un facteur de risque ?\nY a-t-il des facteurs génétiques impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D011505?mesh_terms=Computer+Security&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysrégulation des kinases à tyrosine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des biopsies peuvent révéler des anomalies dans l'activité des kinases."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs tumoraux comme le CA 19-9 peuvent indiquer une activité kinase anormale."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations dans les gènes codant pour les kinases à tyrosine."
}
},
{
"@type": "Question",
"name": "Quels examens d'imagerie sont recommandés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et le scanner peuvent aider à visualiser les tumeurs associées aux kinases."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancers peuvent augmenter le risque de dysrégulation des kinases."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une suractivité des kinases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, perte de poids, et douleurs osseuses peuvent indiquer une suractivité des kinases."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de kinase ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de kinase et de la voie de signalisation affectée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux cancers ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme des masses palpables ou des saignements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue peuvent être communs à plusieurs maladies."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils dans le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver progressivement, nécessitant une surveillance régulière."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des kinases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et l'exercice régulier peuvent réduire le risque de cancers."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages peuvent aider à détecter précocement des anomalies liées aux kinases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins préventifs ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour prévenir les dysfonctionnements des kinases."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque connu pour plusieurs cancers liés aux kinases."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances chimiques peut augmenter le risque de dysfonctionnement des kinases."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases à tyrosine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les inhibiteurs de kinases, comme l'imatinib, sont utilisés pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des mutations spécifiques des kinases."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des traitements sont courants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, nausées et éruptions cutanées sont des effets secondaires fréquents."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée en complément des traitements ciblés."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité varie, mais certains patients peuvent bénéficier d'une rémission prolongée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les kinases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la résistance aux traitements et la progression de la maladie peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles le pronostic ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent aggraver le pronostic et réduire les chances de rémission."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent différer selon le type de cancer et la kinase impliquée."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles des traitements supplémentaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements supplémentaires peuvent être nécessaires pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le tabagisme et l'exposition à des produits chimiques sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de dysfonctionnement des kinases ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente généralement avec l'âge, surtout pour certains cancers."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le virus d'Epstein-Barr, peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs génétiques impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mutations génétiques héréditaires peuvent prédisposer à des dysfonctionnements des kinases."
}
}
]
}
]
}
With the rapid development of image video and tourism economy, tourism economic data are gradually becoming big data. Therefore, how to schedule between data has become a hot topic. This paper first s...
Extensive studies of growing axons have revealed many individual components and protein interactions that guide neuronal morphogenesis. Despite this, however, we lack any clear picture of the emergent...
[This corrects the article DOI: 10.1371/journal.pone.0261200.]....
Quantifying femoral and tibial torsion is crucial in the preoperative planning for derotation surgery in children and adolescents. The use of an ultra-low-dose computed tomography (CT) protocol might ...
This is a retrospective review of 77 children/adolescents (mean age 12.7 years) who underwent a lower extremity CT for torsion measurements on a 64-slice scanner. A stepwise dose reduction (70%, 50%, ...
Torsion measurements at the simulated 30% dose level had equivalent interrater agreement compared to the 100% dose level (ICC ≥ 0.99 for all locations and dose levels). Image quality of almost all dat...
Pediatric torsion measurements of the lower extremities can be performed using an ultra-low-dose protocol without compromising diagnostic confidence....
Aggregation resulting from the self-association of peptide molecules remains a major challenge during preformulation. Whereas certain organic solvents are known to promote aggregation, ethanol (EtOH) ...
While various sinus computed tomography (CT) scoring systems have been proposed and used in the literature, no single system has been identified as superior. The strength of associations between CT sc...
A systematic review of PubMed, CINAHL, Scopus, and the Cochrane Library was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies that reported...
A total of 37 studies were eligible for meta-analysis. Of 8035 patients with chronic rhinosinusitis, 55.6% were male patients and 53.2% had chronic rhinosinusitis with nasal polyps. Analysis by meta-r...
There is a significant moderate association of current CT scoring systems to SIT-40 and SS. Further research should focus on associations of objective measures of olfaction to CT scores of the nasal c...
To determine the prevalence and factors associated with computer vision syndrome in medical students at a private university in Paraguay....
A survey study was conducted in 2021 in a sample of 228 medical students from the Universidad del Pacífico, Paraguay. The dependent variable was CVS, measured with the Computer Visual Syndrome Questio...
The mean age was 22.3 years and 71.5% were women. CVS was present in 82.5% of participants. Higher prevalence of CVS was associated with wearing a framed lens (PR = 1.11, 95% CI: 1.03-1.20). In contra...
Eight out of 10 students experienced CVS during the COVID-19 pandemic. The use of framed lenses increased the presence of CVS, while taking breaks when using electronic equipment at least every 20 min...
There is a lack of universally available biomarker to differentiate rheumatoid arthritis (RA) and psoriatic arthritis (PsA)....
to see if the size of the axillary lymphnodes (ALNs) and the frequency of lymphadenopathy are useful biomarker to differentiate RA and PsA....
Forty RA and 19 PsA patients without previous biologics usage were retrospectively included. Chest CT was assessed for the presence of lymphadenopathy and the size of the largest ALN. Frequency of lym...
Frequency of axillary lymphadenopathy was significantly higher in RA than in PsA (80% vs 31.6%,...
Presence of ALN lymphadenopathy and the short axis of the largest ALN may have a potential utility in differentiating RA and PsA....
Next-generation therapeutics require advanced drug delivery platforms with precise control over morphology and release kinetics. A recently developed microfabrication technique enables fabrication of ...
Memristors, or memristive devices, have attracted tremendous interest in neuromorphic hardware implementation. However, the high electric-field dependence in conventional filamentary memristors result...